-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Bruker, Raises Price Target to $53

Benzinga·05/07/2026 16:12:50
Listen to the news
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $45 to $53.